Skip to main content
TipRanks
Go Ultimate75% OFF

Oncolytics Biotech (ONCY) Ratios

1,682 Followers

Oncolytics Biotech Ratios

ONCY's free cash flow for Q3 2026 was C$-6.98M. For the 2026 fiscal year, ONCY's free cash flow was increased by C$5.97K and operating cash flow was C$-6.99M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio1.122.829.019.0516.69
Quick Ratio1.122.829.019.0516.69
Cash Ratio0.852.388.242.9615.34
Solvency Ratio-1.84-2.23-1.80-1.73-2.11
Operating Cash Flow Ratio-2.40-4.03-6.71-5.92-8.34
Short-Term Operating Cash Flow Coverage0.000.000.000.000.00
Net Current Asset ValueC$ -6.23MC$ 4.67MC$ 26.92MC$ 24.85MC$ 35.12M
Leverage Ratios
Debt-to-Assets Ratio0.070.050.010.010.01
Debt-to-Equity Ratio-0.150.180.020.010.02
Debt-to-Capital Ratio-0.170.150.020.010.02
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio-2.003.371.411.411.27
Debt Service Coverage Ratio0.000.000.000.000.00
Interest Coverage Ratio0.000.000.000.000.00
Debt to Market Cap0.000.000.000.000.00
Interest Debt Per Share0.010.010.010.010.01
Net Debt to EBITDA0.220.431.710.601.97
Profitability Margins
Gross Profit Margin0.00%0.00%0.00%0.00%0.00%
EBIT Margin0.00%0.00%0.00%0.00%0.00%
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin0.00%0.00%0.00%0.00%0.00%
Pretax Profit Margin0.00%0.00%0.00%0.00%0.00%
Net Profit Margin0.00%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT100.28%100.41%100.35%100.34%100.19%
EBT Per EBIT99.84%90.27%81.84%91.93%100.08%
Return on Assets (ROA)-276.44%-157.08%-52.97%-51.10%-45.73%
Return on Equity (ROE)551.71%-530.00%-74.60%-71.98%-58.12%
Return on Capital Employed (ROCE)-1413.55%-259.13%-72.39%-61.94%-48.45%
Return on Invested Capital (ROIC)-1250.57%-253.92%-72.12%-61.54%-48.12%
Return on Tangible Assets-276.44%-157.08%-52.97%-51.10%-45.73%
Earnings Yield-25.02%-31.55%-17.40%-14.89%-22.31%
Efficiency Ratios
Receivables Turnover0.000.000.000.000.00
Payables Turnover0.000.080.280.130.61
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover0.000.000.000.000.00
Asset Turnover0.000.000.000.000.00
Working Capital Turnover Ratio0.000.000.000.000.00
Cash Conversion Cycle0.00-4560.40-1322.66-2729.84-601.29
Days of Sales Outstanding0.000.000.000.000.00
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding0.004560.401322.662729.84601.29
Operating Cycle0.000.000.000.000.00
Cash Flow Ratios
Operating Cash Flow Per Share-0.21-0.35-0.42-0.40-0.42
Free Cash Flow Per Share-0.21-0.36-0.42-0.40-0.42
Dividend Paid and CapEx Coverage Ratio-3352.00-112.83-3556.00-424.64-78.45
Capital Expenditure Coverage Ratio-3352.00-112.83-3556.00-424.64-78.45
Operating Cash Flow Coverage Ratio-26.03-25.34-67.25-62.61-34.25
Operating Cash Flow to Sales Ratio0.000.000.000.000.00
Free Cash Flow Yield-17.50%-27.07%-24.08%-18.28%-24.16%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-2.92-3.21-5.75-6.71-4.48
Price-to-Sales (P/S) Ratio0.000.000.000.000.00
Price-to-Book (P/B) Ratio-22.0516.804.294.832.60
Price-to-Free Cash Flow (P/FCF) Ratio-5.71-3.69-4.15-5.47-4.14
Price-to-Operating Cash Flow Ratio-5.72-3.73-4.15-5.48-4.19
Price-to-Earnings Growth (PEG) Ratio-0.080.001.240.55-2.15
Enterprise Value Multiple-3.79-2.45-4.14-6.24-2.60
Enterprise Value108.59M85.63M83.69M116.79M53.42M
EV to EBITDA-3.79-2.45-4.14-6.24-2.60
EV to Sales0.000.000.000.000.00
EV to Free Cash Flow-5.40-3.15-2.94-4.99-2.35
EV to Operating Cash Flow-5.40-3.18-2.94-5.00-2.38
Tangible Book Value Per Share-0.050.080.410.460.67
Shareholders’ Equity Per Share-0.050.080.410.460.67
Tax and Other Ratios
Effective Tax Rate-0.00-0.00-0.00-0.00-0.00
Revenue Per Share0.000.000.000.000.00
Net Income Per Share-0.30-0.41-0.30-0.33-0.39
Tax Burden1.001.001.001.001.00
Interest Burden1.000.901.001.001.00
Research & Development to Revenue0.000.000.000.000.00
SG&A to Revenue0.000.000.000.000.00
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality0.700.851.030.940.85

Currency in CAD